Pharco

Alexandria, Egypt Founded: 1983 • Age: 43 yrs
Pharmaceutical products and Hepatitis C treatments are manufactured and distributed.

About Pharco

Pharco is a Healthcare company based in Alexandria (Egypt) founded in 1983 by Hassan Abbas Helmy. Pharmaceutical products and Hepatitis C treatments are manufactured and distributed. Pharco offers products and services including Hepatitis C Treatments and General Pharmaceuticals. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Pharco Pharmaceuticals.

Company details

Pharco was founded in 1983 in Alexandria, Egypt, within the pharmaceutical sector. Research and development are conducted alongside manufacturing and distribution of a diverse range of medications. A primary emphasis is placed on treatments for Hepatitis C. Operations are supported by initiatives aimed at public health, with activities centered in Egypt.

  • Headquarters Alexandria, Egypt
  • Founders Hassan Abbas Helmy
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website pharco.org
  • Social LinkedIn X Facebook
  • Legal Name Pharco Pharmaceuticals
Key Metrics
  • Latest Funding Round
    $1.87M (USD), Debt – Conventional

    Dec 2014

  • Investors

Products & Services of Pharco

Pharco offers a comprehensive portfolio of products and services, including Hepatitis C Treatments and General Pharmaceuticals.

Hepatitis C Treatments
Pharmaceutical Products

Medications for Hepatitis C are developed and distributed to cure patients globally

General Pharmaceuticals
Healthcare Products

Various drugs are produced for public health and industrial applications

Funding Insights of Pharco

  • Total Rounds 1
  • Last Round Debt – Conventional β€” $1.87M
  • First Round $1.87M

    (Dec 2014)

  • Investors Count 1

All 1 funding rounds of Pharco with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2014$1.87MDebt – Conventional––
Valuation history

1 investors in total: 1 institutional.

Investors in Pharco

Pharco has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Merodis.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Merodis is engaged in providing tailored M&A advisory services.
merodis.comBrussels, Belgium
Premium access

Investor details for Pharco

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Pharco

3 people are tracked at Pharco (1 in leadership, 1 in board & advisors, 1 in team).

NameRoleGroup
Hassan Abbas Helmy
FounderLeadership
Hassan A. Helmy
Founder & PresidentBoard & advisors
Sherine Helmy
ChairmanTeam
Premium access

Complete people profiles for Pharco

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Pharco

2 dated milestones of Pharco across 31 years, from founding to its latest funding, stage changes and deals.

  1. Founded Pharco is founded.
  2. Funding First funding round of $1.9M.

Web traffic of Pharco

The website of Pharco (pharco.org) receives about 4.4K visits a month and ranks #2,455,432 among all websites worldwide, #3,365 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    4.4K

    ▼ 48.8% vs previous month

  • Unique visitors
    3.9K

    per month

  • Global rank
    #2,455,432

    among all websites

  • Category rank
    #3,365

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Pharco. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cphi-online.com
100%
#227,074View details
cipla.com
41%
200.9K#203,362View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Pharco

Pharco was founded in 1983 and raised its 1st funding round 31 years after it was founded.

Pharco is headquartered in Alexandria, Egypt.

Pharco was founded in 1983 in Alexandria, Egypt, within the pharmaceutical sector. Research and development are conducted alongside manufacturing and distribution of a diverse range of medications. A primary emphasis is placed on treatments for Hepatitis C. Operations are supported by initiatives aimed at public health, with activities centered in Egypt.

Pharco offers Hepatitis C Treatments and General Pharmaceuticals.

Pharco has 1 investor. Key investors include Merodis.

Pharco operates through Pharco Pharmaceuticals.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available